Dr. Kenneth Graham

Dr. Kenneth B. Graham is a board-certified ophthalmologist specializing in the medical and surgical management of retinal conditions. He earned his medical degree from the University of Alabama School of Medicine, where he graduated with a full scholarship and conducted research at the National Institutes of Health through a Howard Hughes Medical Institute scholarship. Dr. Graham completed an internship at the Mayo Clinic, followed by ophthalmology residency and a two-year fellowship in diseases of the retina at Harvard Medical School/Massachusetts Eye and Ear Infirmary, where he served as Chief Fellow.

Dr. Graham has been involved in groundbreaking clinical research, including participation in the initial development of Lucentis and Avastin for age-related macular degeneration and serving as principal investigator for the phase 3 clinical trial of Brolucizumab. His areas of expertise include retinal detachments, diabetic retinopathy, macular degeneration, macular holes, and retinal vein occlusions. He is a member of several professional societies, including the American Society of Retina Specialists and the American Academy of Ophthalmology.